WallStSmart

Maximus Inc (MMS)vsThomson Reuters Corporation Common Shares (TRI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Thomson Reuters Corporation Common Shares generates 39% more annual revenue ($7.48B vs $5.37B). TRI leads profitability with a 20.1% profit margin vs 6.9%. MMS appears more attractively valued with a PEG of 2.06. MMS earns a higher WallStSmart Score of 64/100 (C+).

MMS

Buy

64

out of 100

Grade: C+

Growth: 6.0Profit: 6.5Value: 10.0Quality: 8.5
Piotroski: 6/9Altman Z: 2.69

TRI

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 7.5Value: 4.7Quality: 5.3
Piotroski: 5/9Altman Z: 2.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MMSUndervalued (+75.2%)

Margin of Safety

+75.2%

Fair Value

$305.14

Current Price

$67.81

$237.33 discount

UndervaluedFair: $305.14Overvalued
TRISignificantly Overvalued (-298.8%)

Margin of Safety

-298.8%

Fair Value

$22.37

Current Price

$87.40

$65.03 premium

UndervaluedFair: $22.37Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMS4 strengths · Avg: 9.3/10
P/E RatioValuation
10.4x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
146.5%10/10

Earnings expanding 146.5% YoY

Return on EquityProfitability
22.1%9/10

Every $100 of equity generates 22 in profit

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

TRI2 strengths · Avg: 8.5/10
Profit MarginProfitability
20.1%9/10

Keeps 20 of every $100 in revenue as profit

Operating MarginProfitability
26.6%8/10

Strong operational efficiency at 26.6%

Areas to Watch

MMS4 concerns · Avg: 3.0/10
PEG RatioValuation
2.064/10

Expensive relative to growth rate

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

Debt/EquityHealth
1.013/10

Elevated debt levels

Revenue GrowthGrowth
-4.1%2/10

Revenue declined 4.1%

TRI3 concerns · Avg: 2.7/10
P/E RatioValuation
26.6x4/10

Moderate valuation

PEG RatioValuation
9.702/10

Expensive relative to growth rate

EPS GrowthGrowth
-42.6%2/10

Earnings declined 42.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : MMS

The strongest argument for MMS centers on P/E Ratio, EPS Growth, Return on Equity.

Bull Case : TRI

The strongest argument for TRI centers on Profit Margin, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 26.6%.

Bear Case : MMS

The primary concerns for MMS are PEG Ratio, Profit Margin, Debt/Equity.

Bear Case : TRI

The primary concerns for TRI are P/E Ratio, PEG Ratio, EPS Growth.

Key Dynamics to Monitor

MMS profiles as a value stock while TRI is a mature play — different risk/reward profiles.

MMS carries more volatility with a beta of 0.56 — expect wider price swings.

TRI is growing revenue faster at 5.2% — sustainability is the question.

TRI generates stronger free cash flow (607M), providing more financial flexibility.

Bottom Line

MMS scores higher overall (64/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Maximus Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Maximus, Inc. provides Business Process Services (BPS) to government health and human services programs worldwide. The company is headquartered in Reston, Virginia.

Visit Website →

Thomson Reuters Corporation Common Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Thomson Reuters Corporation provides business information services in the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Want to dig deeper into these stocks?